SIRO Clinpharm Overview
- Founded
-
1996
- Status
-
Private
- Employees
-
250
- Latest Deal Type
-
IBO
- Financing Rounds
-
4
- Investments
-
1
SIRO Clinpharm General Information
Description
Provider of clinical drug development services. The company supports drug trials from Phase II to Phase IV and beyond post-launch of products. It also offers a range of services, from clinical operations to data services, data analytics and medical writing in compliance with international standards.
Contact Information
Website
www.siroclinpharm.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Primary Office
- Kalpataru Prime, 1st floor, Unit Nos. 3 & 4, Road No. 16, Wagle
- Industrial Estate, Thane (West)
- Mumbai, Maharashtra 400604
- India
+91 022 0000 0000
SIRO Clinpharm Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SIRO Clinpharm Executive Team (7)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Vatsal Shah | Chief Operating Officer | ||
| Indronil Bose | Chief Human Resources Officer | ||
| Gautam Daftary | Founder & Chairman |
SIRO Clinpharm Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 0000000 | Self | Founder & Chairman | 000 0000 |
SIRO Clinpharm Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
SIRO Clinpharm Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 0000000 | 18-Apr-2008 | 0000000000 | Decision/Risk Analysis | 000000 00 |